Kang Stem Biotech earns patent for rheumatoid arthritis stem cell cure

23:29
[Andrei Hagiu] Which products will benefit and which will be disrupted by generative AI
19:11
Lt. Gen. Ju Il-suk picked as marine corps chief
19:08
Prosecutors seek 5-year prison term for Samsung chief in merger retrial
18:31
UN talks on plastic pollution treaty begin with grim outlook
18:01
Bill proposed to mandate antismoking warnings on e-cigarettes
17:59
Mercedes-Benz donates W500m for child protection center in Incheon
17:50
BAT debuts synthetic nicotine e-cigarettes in Korea
17:48
[More than APT] Changing the value of 'home'
17:29
[Herald Gallery] Raum der Gedanken
17:14
Seoul shares jump over 1.3% on tech gains, Trump's pick for treasury post

Kang Stem Biotech earns patent for rheumatoid arthritis stem cell cure

July 20, 2016 - 10:41 By 정민경

[DISCLOSURE] Kang Stem Biotech (217730) announced on July 20 that it has earned patent rights for a pharmaceutical composition comprising stem cells treated with NOD2 agonist for immune disorders and inflammatory diseases such as rheumatoid arthritis.

정민경